NCT05429749 is a Phase 4 clinical trial of Ferinject in Hip Fractures, sponsored by Seoul National University Bundang Hospital.

Who is sponsoring NCT05429749?

NCT05429749 is sponsored by Seoul National University Bundang Hospital.

What drugs are being tested in NCT05429749?

Interventions in NCT05429749: Ferinject, Normal saline.

What condition does NCT05429749 study?

NCT05429749 studies Hip Fractures.

Is NCT05429749 still recruiting?

NCT05429749 is currently status unknown. Last updated 23 June 2022.

Last reviewed 2022-06-23 · How we verify

NCT05429749

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intravenous Iron Supplement to Prevent Postoperative Delirium After Hip Fracture Surgery

Status unknown Phase 4 Last updated 23 June 2022

What this trial tests

Phase 4 trial testing Ferinject in Hip Fractures in 264 participants. Status unknown.

Timeline

30 July 2020

Primary endpoint
31 December 2023

31 December 2024

Quick facts

Lead sponsor	Seoul National University Bundang Hospital
Phase	Phase 4
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	264
Start date	30 July 2020
Primary completion	31 December 2023
Estimated completion	31 December 2024
Sites	1 location across South Korea

Drugs / interventions tested

Ferinject — full drug profile →
Normal saline

Conditions studied

Hip Fractures — all drugs for Hip Fractures →

Sponsor

Seoul National University Bundang Hospital

Who can join

65 and older, any sex, with Hip Fractures. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a clinical trial to evaluate the effect of intravenous iron supplement with Ferinject (Ferric Carboxymaltose) in preventing postoperative delirium after hip fracture surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Ferinject

Trials testing the same drug.

NCT06061393 — Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia · Phase 4 · unknown
NCT05759078 — Effect of INtravenous FERRic Carboxymaltose Onmortality and Cardiovascular Morbidity, and Quality of Life in Iron Defici · Phase 4 · recruiting
NCT05226169 — Efficacy and Safety oF FErric CarboxymalTose in Patients With Advanced Gastric Cancer(EFFECT-AGC) · Phase 3 · recruiting
NCT05114278 — Effect of Intravenous Iron Supplementation on Celiac Disease Remission (IRONCEL) · Phase 4 · unknown
NCT04915820 — Iron and COVID-19 Vaccine Response · NA · completed

Other recruiting trials for Hip Fractures

Currently open trials in the same condition.

NCT07239817 — PENG Block + LIA For Endoprosthesis Surgery With Anterior Approach · NA · recruiting
NCT07002723 — Effects of Esketamine Combined With Dexmedetomidine on Postoperative Sleep Quality · NA · recruiting
NCT06893406 — Cervical Myelopathy in Hip Fracture Patients · NA · recruiting
NCT06565910 — Bupivacaine Liposome Plus Bupivacaine or Ropivacaine for Pericapsular Nerve Group Block in Hip Arthroplasty (PENG) · Phase 4 · recruiting
NCT06455813 — What Laxative Should be Used After Hip Fracture Surgery? · Phase 4 · recruiting

Other Seoul National University Bundang Hospital trials

Trials by the same sponsor.

NCT07459725 — Comparison of EEG-Timed vs. Repetitive Robot Therapy for Chronic Stroke · NA · not yet recruiting
NCT07455279 — Surface Electromyographic Analysis of Normal Swallowing in Children: An Exploratory Study · not yet recruiting
NCT07477574 — Muscle-Specific Multimodal AI for Sarcopenia Diagnosis · NA · not yet recruiting
NCT07505290 — Efficacy of the Korean PEERS® for Preschoolers (PEERS®-PS-K) Social Skills Intervention: A Randomized Controlled Trial f · NA · active not recruiting
NCT07305662 — Exploring the Effects of Korean-Style Mediterranean Diet (KORMED) and Physical Activity Measurement in Patients With MGU · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05429749 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seoul National University Bundang Hospital
Last refreshed: 23 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05429749.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing